|
FY2025
12 months to Dec 27, 2025
|
FY2024
12 months to Dec 28, 2024
|
FY2023
12 months to Dec 30, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Jan 1, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Net product sales | |||||
| Total net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Intellectual property legal fees | |||||
| Selling, general and administrative | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Other income, net: | |||||
| Interest income (expense), net | |||||
| Interest income, net | |||||
| Other income, net | |||||
| Total other income, net | |||||
| Loss before provision for income taxes | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Deemed dividend on warrant modification | |||||
| Net loss attributable to common stock | |||||
| Loss per share: | |||||
| Basic | |||||
| Diluted | |||||
| Weighted-average common shares outstanding: | |||||
| Basic | |||||
| Diluted | |||||
Loading...